Clinical observation of high dose cinobufocini in attenuation and treatment of infection and granulocytopenia during combined chemotherapy of malignant blood disease

Yue Bei-bei; Xia Le-san; Yuan Cheng-tai; Wu Qing; Xiang Ming-qing; Dong Shao-kun; Zhou Zheng-ju

doi:10.1007/BF02947288

Your Location：

Home >

Browse articles >

Clinical observation of high dose cinobufocini in attenuation and treatment of infection and granulocytopenia during combined chemotherapy of malignant blood disease

Updated：2021-08-27

- Clinical observation of high dose cinobufocini in attenuation and treatment of infection and granulocytopenia during combined chemotherapy of malignant blood disease
- Chinese Journal of Integrative Medicine Vol. 1, Issue 1, Pages: 43-46(1995)
- Affiliations：
  
  The First People’s Hospital of Shashi
- Author bio：
- Funds：
- DOI：10.1007/BF02947288
  CLC：
- Published：1995，
Scan for full text
Yue, Bb., Xia, Ls., Yuan, Ct. et al. Clinical observation of high dose cinobufocini in attenuation and treatment of infection and granulocytopenia during combined chemotherapy of malignant blood disease., CJIM 1, 43–46 (1995). https://doi.org/10.1007/BF02947288

Yue Bei-bei, Xia Le-san, Yuan Cheng-tai, et al. Clinical observation of high dose cinobufocini in attenuation and treatment of infection and granulocytopenia during combined chemotherapy of malignant blood disease. [J]. Chinese Journal of Integrative Medicine 1(1):43-46(1995)
Yue, Bb., Xia, Ls., Yuan, Ct. et al. Clinical observation of high dose cinobufocini in attenuation and treatment of infection and granulocytopenia during combined chemotherapy of malignant blood disease., CJIM 1, 43–46 (1995). https://doi.org/10.1007/BF02947288 DOI：

Yue Bei-bei, Xia Le-san, Yuan Cheng-tai, et al. Clinical observation of high dose cinobufocini in attenuation and treatment of infection and granulocytopenia during combined chemotherapy of malignant blood disease. [J]. Chinese Journal of Integrative Medicine 1(1):43-46(1995) DOI： 10.1007/BF02947288.

摘要

The use of high dose cinobufocini in attenuation and treatment of infection and granulocytopenia during combined chemotherapy was observed in patients with malignant blood diseases. The study was designed in such a way that each patient served also as part of the control group. The test group included 18 males and 12 females

ranged in ages between 16 and 66 (averaged 34). Sixty-two experiments were run on 20 patients with acute leukemia

8 with malignant lymphoma and 2 with multiple myeloma. The test group was treated with high dosages of cinobufocini. In each case

instances of infection were significantly decreased and the number of granulocytes was not markedly changed by the treatment. The results of this study suggest that high dosage cinobufocini therapy may significantly reduce the risk of infection and the degree and duration of granulocytopenia associated with chemotherapy for malignant blood diseases. Also

high dosage cinobufocini therapy is simple

convenient and causes little or no side effects.

Abstract

ranged in ages between 16 and 66 (averaged 34). Sixty-two experiments were run on 20 patients with acute leukemia

8 with malignant lymphoma and 2 with multiple myeloma. The test group was treated with high dosages of cinobufocini. In each case

high dosage cinobufocini therapy is simple

convenient and causes little or no side effects.

关键词

malignant blood diseasescinobufocinicombined chemotherapyinfectiongranulocytopenia

Keywords

malignant blood diseasescinobufocinicombined chemotherapyinfectiongranulocytopenia

references

1974;(1): 39, (2):42.

1984; 4(5) 257.

1985;(4): 38.

1991: 152–172,288–308.

1974; (2): 19.

1974;(3):42.

1986; 7(7):405.

1989;22(4): 236.

FULL TEXT LINK

More>

Views

682

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Regulatory effect of Langchuang serial recipes on T-lymphocyte subsets Th and Tc in patients with systemic lupus erythematosus

Related Author

No data

Related Institution

Department of Rheumatology and Immunology, Hospital of Integrative Chinese and Western Medicine

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰